B7-H1 up-regulation on dendritic-like leukemia cells suppresses T cell immune function through modulation of IL-10/IL-12 production and generation of Treg cells-Reference-Cited by-同舟云学术

B7-H1 up-regulation on dendritic-like leukemia cells suppresses T cell immune function through modulation of IL-10/IL-12 production and generation of Treg cells

Published:2009-07 Issue:7 Volume:33 Page:948-957
ISSN:0145-2126
Container-title:Leukemia Research
language:en
Short-container-title:Leukemia Research

Author:

Ge Wei,Ma Xiaotong,Li Xin,Wang Yafei,Li Changhong,Meng Hengxing,Liu Xiaofan,Yu Zhen,You Shengguo,Qiu Lugui

Publisher

Elsevier BV

Subject

Cancer Research,Oncology,Hematology

Reference34 articles.

1. Leukemic dendritic cells: potential for therapy and insights towards immune escape by leukemic blasts;Mohty;Leukemia,2002

2. Immunotherapeutic strategies in acute lymphoblastic leukaemia relapsing after stem cell transplantation;Blair;Blood Rev,2005

3. Induction of BCR-ABL-specific immunity following vaccination with chaperone-rich cell lysates derived from BCR-ABL+ tumor cells;Zeng;Blood,2005

4. Leukemia-derived immature dendritic cells differentiate into functionally competent mature dendritic cells that efficiently stimulate T cell responses;Cignetti;J Immunol,2004

5. Induction of leukemia-specific cytotoxic T cells response by cross-presentation of late-apoptotic leukemic blasts by autologous dendritic cells of nonleukemic origin;Spisek;Cancer Res,2002

Cited by 37 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. USP13 promotes acute myeloid leukemia cell proliferation and autophagy by promoting ATG5;Tissue and Cell;2024-12

2. Acute myeloid leukemias with JAK2/STAT mutations are associated with PD-L1 upregulation;Leukemia & Lymphoma;2023-07-10

3. Dissecting big RNA-Seq cancer data using machine learning to find disease-associated genes and the causal mechanism;Big Data Analytics in Chemoinformatics and Bioinformatics;2023

4. Dendritic cell-based cancer immunotherapy in the era of immune checkpoint inhibitors: From bench to bedside;Life Sciences;2022-05

5. Targeting PD-1/PD-L1 pathway in myelodysplastic syndromes and acute myeloid leukemia;Experimental Hematology & Oncology;2022-03-02